the aid library

LIST OPTIONS

Filter

414

Keeping the vector out: housing improvements for vector control and sustainable development

Kraef, C.; Röbbel, N. World Health Organization WHO (2017) C_WHO

Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u... more

Download (288)

View PDF (262)

Antibiotic Use for Sepsis in Neonates and Children: 2016 Evidence Update

Fuchs A., J. Bielickia, S. Mathur, et.al. World Health Organization (2016) C_WHO

Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.

Download (198)

View PDF (213)

Report from the scoping consultation on severe bacterial infections among people with advanced HIV disease

World Health Organization WHO (2022) CC

Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re... more

External Link

HIV-Associated Tuberculosis: A sub-Saharan African Perspective

Mukhtar A Adeiza, Abdullah A Abba, Juliana U Okpapi (2014) CC

Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14

Download (188)

View PDF (222)

Situation Analysis and Recommendations: Antibiotic Use and Resitance in Mozambique

The Center for Disease Dynamics, Economics & Policy CDDEP (2015) C2

The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate... more

External Link

Antibiotic Prescribing in DR Congo: A Knowledge, Attitude and Practice Survey among Medical Doctors and Students

Thriemer K, Katuala Y, Batoko B, Alworonga J-P, Devlieger H, et al. PLoS ONE (2013) CC

Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo.

Download (1102)

View PDF (2405)

Serious Childhood Problemes in Countries Limited Resources

WHO (2004)

Background book on Management of the Child with a Serious Infection or Severe Malnutrition

External Link

Best Practices for Environmental Cleaning in Healthcare Facilities: in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2019) C_CDC

Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o... more

Download (276)

View PDF (311)

Faecal Sludge And Septage Treatment. A guide for low and middle income countries.

Tayler, K. Practical Action Publishing (2018) CC

It explains the importance of faecal sludge management in urban areas in which many people rely on on-site and decentralized sanitation facilities and emphasizes the place of treatment in the overall sanitation service chain. It defines terms used throughout the book, explains why faecal sludge and ... more

Download (116)

View PDF (178)

Guia de diagnostico y tratamiento de COVID-19 en unidades de terapia intensiva - version mayo de 2020

Sociedad Boliviana de Medicina Crítica y Terapia Intensiva Sociedad Boliviana de Medicina Crítica y Terapia Intensiva Ministerio de Salud Bolivia (2020) CC

Guidelines for the diagnosis and treatment of COVID-19 in intensive care units

External Link

Improving nutrition outcomes with better water, sanitation, &hygiene: Practical solutions for policy and programmes

Renuka Bery, Sophie Boisson, Lizette Burgers et al. WHO, USAID, UNICEF (2015) C_WHO

This document provides an overview of the evidence of nutrition gains that can be achieved with improved WASH, a description of key WASH practices, and practical knowledge and guidance on how to integrate WASH into nutrition programmes, including important monitoring and evaluation (M&E) aspects. Th... more

Download (283)

View PDF (245)

Health workers’ education and training on antimicrobial resistance: curricula guide
recommended

World Health Organization WHO (2019) C_WHO

This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ... more

Download (183)

View PDF (177)

COVID-19 infection prevention and control for primary care, including general practitioner practices, dental clinics and pharmacy settings. First Update

European Centre for Disease Prevention and Control ECDC (2020) C1

Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels and mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is usually guided by national policies for specific heal... more

External Link

Antimicrobial resistance and the nurse’s role

Agne Diminskyte (2016) C2

Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also statistics reveal that because of antimicrobial resistance patients’ morbidity and mortality is increa... more

Download (154)

View PDF (235)

WHO Meeting on Buruli ulcer and other skin NTDs. Final report.

World Health Organization WHO (2019) C_WHO

The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019

Download (131)

View PDF (117)

Antimicrobial Resistance Curriculum Assessment Tool for Medical Education

World Health Organisation (WHO) (2024) C_WHO

The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ... more

Download (815)

View PDF (2188)

Childhood TB - Training Toolkit

International Union Against Tuberculosis and Lung Disease (2014) CC

The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.

Download (80)

View PDF (75)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

External Link

A Is tuberculosis elimination a feasible goal in Colombia by 2050?

López, L.; Y. Keynan, D. Marin et al. (2019) CC

Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122 Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t... more

Download (167)

View PDF (159)

COVID-19: Chloroquine and hydroxychloroquine research

World Health Organization WHO (2020) C_WHO

This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri... more

Health workers’ education and training on antimicrobial resistance: curricula guide recommended

Health workers’ education and training on antimicrobial resistance: curricula guide
recommended